© 2024 SEISMIC TX. ALL RIGHTS RESERVED.
Showcasing major shift in discovery and development of immunology therapies enabled by machine learning
Watertown, Mass., May 29, 2024 – Seismic Therapeutic, Inc., the machine learning immunology company, today announced that company management will participate in the following June investor conferences:
Jefferies Global Healthcare Conference
Date: Tuesday, June 4, 2024
Location: New York, NY
Format: 1×1 meetings
Leerink Partners Biopharma Private Company Connect
Date: Tuesday, June 25 – Wednesday, June 26, 2024
Location: Virtual
Format: 1×1 meetings
Morgan Stanley 3rd Annual Life Sciences AI Summit
Date: Wednesday June 26 – Thursday, June 27, 2024
Location: New York, NY
Format: Panel and 1×1 meetings
About Seismic Therapeutic
Seismic Therapeutic™ is a biotechnology company making a major shift in how immunology therapies are discovered and developed, enabled by machine learning. The company has a growing preclinical stage best-in-class and first-in-class biologics pipeline, derived from its integrated IMPACT platform, to control dysregulated adaptive immunity and address multiple autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub. For more information, please visit www.seismictx.com and follow us on LinkedIn and on X @Seismic_Tx.
Media Contact
Kathryn Morris, The Yates Network
914-204-6412
kathryn@theyatesnetwork.com
Investor Contact
Emiley Demick, Precision AQ (formerly known as Stern IR)
212-362-1200
emiley.demick@precisionaq.com
This links to an external website.